Clinical Trial Update: Testing a Primary Care Model for the Treatment of Opioid Dependence Using Long-acting Injectable Naltrexone (Vivitrol). [NA]

View source ↗

Summary

A clinical trial evaluating a primary care model for treating opioid use disorder with the long-acting injectable naltrexone (Vivitrol) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Yale University | Conditions: Drug Dependence | NA | Status: WITHDRAWN